Pictet Asset Management (Switzerland)’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$684K Sell
58,080
-5,678
-9% -$64.6K ﹤0.01% 1101
2023
Q1
$733K Sell
63,758
-38,565
-38% -$477K ﹤0.01% 1081
2022
Q4
$1.27M Buy
102,323
+12,564
+14% +$160K ﹤0.01% 980
2022
Q3
$1.18M Sell
89,759
-1,591
-2% -$23.5K ﹤0.01% 986
2022
Q2
$1.28M Buy
91,350
+4,666
+5% +$62.4K ﹤0.01% 1010
2022
Q1
$1.29M Buy
86,684
+2,047
+2% +$28K ﹤0.01% 1026
2021
Q4
$1.15M Buy
84,637
+2,273
+3% +$32.2K ﹤0.01% 1063
2021
Q3
$1.21M Buy
+82,364
New +$1.39M ﹤0.01% 1056

Other funds holding SBRA

Pictet Asset Management (Switzerland)'s SBRA Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Sabra Healthcare REIT (SBRA) stake by 8.9% in Q2 2023, selling an estimated $64.6K and leaving 58,080 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Pictet Asset Management (Switzerland) first reported a position in SBRA in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.29M in Q1 2022. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 58,080 shares of Sabra Healthcare REIT worth $684K as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 5,678 Sabra Healthcare REIT shares in Q2 2023, an estimated $64.6K.
  • Sabra Healthcare REIT made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1101 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Sabra Healthcare REIT position peaked at $1.29M in Q1 2022.
  • 325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.